Skip to main content

ORIGINAL RESEARCH article

Front. Med.
Sec. Intensive Care Medicine and Anesthesiology
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1413191

The median effective concentration of epidural ropivacaine with different doses of dexmedetomidine for motor blockade: An up-down sequential allocation study

Provisionally accepted
Ji-Xiang Wan Ji-Xiang Wan Chao Lin Chao Lin Zhi-Qiang Wu Zhi-Qiang Wu Duan Feng Duan Feng Yuan Wang Yuan Wang Fang-Jun Wang Fang-Jun Wang *
  • Affiliated Hospital of North Sichuan Medical College, Nanchong, China

The final, formatted version of the article will be published soon.

    Recent studies have shown that dexmedetomidine can be safely used in peripheral nerve blocks and spinal anesthesia. Epidural administration of dexmedetomidine produces analgesia and sedation, prolongs motor and sensory block time, extends postoperative analgesia, and reduces the need for rescue analgesia. This investigation seeks to identify the median effective concentration (EC 50 ) of ropivacaine for epidural motor blockade, and assess how incorporating varying doses of dexmedetomidine impacts this EC 50 value.Design: Prospective, double-blind, up-down sequential allocation study.Setting: Operating room, post-anesthesia care unit, and general ward.Interventions: One hundred and fifty patients were allocated into five groups in a randomized, double-blinded manner as follows: NR (normal saline combined with ropivacaine) group, RD 0.25 (0.25 μg/kg dexmedetomidine combined with ropivacaine) group, RD 0.5 (0.5 μg/kg 0.624% (95% CI, 0.550-0.728%) in the RD 0.25 group, 0.549% (95% CI, 0.456-0.660%) in the RD 0.5 group, 0.463% (95% CI, 0.408-0.527%) in the RD 0.75 group, and 0.435% (95% CI, 0.390-0.447%) in the RD 1.0 group.The EC 50 of the NR group and the RD 0.25 group were significantly higher than that of the RD 0.75 and the RD 1.0 groups, and the EC 50 of the RD 0.5 group was significantly higher than that of the RD 1.0 group.The EC 50 of epidural ropivacaine required to achieve motor block was 0.677% in the NR group, 0.624% in the RD 0.25 group, 0.549% in the RD 0.5 group, 0.463% in the RD 0.75 group, and 0.435% in the RD 1.0 group. Dexmedetomidine as an adjuvant for ropivacaine dose-dependently reduce the EC 50 of epidural ropivacaine for motor block and shorten the onset time of epidural ropivacaine block. The optimal dose of dexmedetomidine combined with ropivacaine for epidural anesthesia was 0.5 μg/kg.

    Keywords: Dexmedetomidine, epidural, Median effective concentration, Motor blockade, Ropivacaine

    Received: 07 May 2024; Accepted: 26 Jul 2024.

    Copyright: © 2024 Wan, Lin, Wu, Feng, Wang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Fang-Jun Wang, Affiliated Hospital of North Sichuan Medical College, Nanchong, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.